PNT — POINT Biopharma Global Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
- $1.33bn
- $998.03m
- $226.58m
Annual cashflow statement for POINT Biopharma Global, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.009 | -13.4 | -45.9 | 98.3 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | — | 1.85 | 2.31 | 1.59 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.009 | 3.22 | -1.18 | 80.9 |
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | 0 | -8.31 | -44.7 | 184 |
| Capital Expenditures | — | -9.8 | -8.8 | -12.8 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0 | — | — | -253 |
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 0 | -9.8 | -8.8 | -266 |
| Financing Cash Flow Items | 0 | -0.325 | 0 | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0 | 28.7 | 282 | 130 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0 | 10.5 | 228 | 47.6 |